Clinician in silhouette looking into a microscope

Bring skin longevity into your practice.

We’re partnering with a limited group of dermatology, aesthetic and longevity practices to launch Formula 01 in 2027.

Request the clinical information to see if it fits your practice, and join the founding network.

Request clinical information
Internal skincare

The foundational layer of your aesthetic care plan.

Every treatment you offer asks skin to repair itself, and the result depends on the biology doing the repair. Formula 01 supports that biology every day, between appointments, so everything you do in clinic has more to build on.

Topical skincare

Support from the outside

Serums, retinoids, barrier care and SPF. Daily, on the surface.

Established

In-clinic treatments

A targeted stimulus

Lasers, energy devices and injectables. In sessions, months apart.

Established

Formula 01

Support from within

Daily support for the cells that rebuild skin, so every other layer works better.

The foundation

Our founding practices

78% of US adults already take supplements. Now there’s an evidence-based protocol for skin you can recommend.

Skin longevity is a new way of thinking about skin, and it can’t be learned from a shelf. Patients arrive with a model built by the skincare aisle. Changing it takes a conversation with someone they trust, and that conversation happens in your room.

So we built the partnership around you. Founding practices are trained and certified in skin longevity through our academy, and we educate patients alongside you through PR, events, communications and social media.

Learn more, today. 

Request clinical information
Two Formula 01 sachets held in a polished laboratory clamp stand
  • The Skin Longevity Academy

    Training and certification for your team, with the protocols and patient materials to put Formula 01 to work.

  • We promote our partners

    PR, press, events and social built around our founding practices, so patients come asking for you.

  • Your co-branded ordering page

    We build your patient refill page and handle subscriptions, shipping and support. You recommend, we fulfill.

Dr. François-Xavier Pellay, Chief Scientific Officer of Epillon
From our Chief Scientific Officer

Nobody was funding this research.

So we built a company to do it.

For a century, skincare has invested in what goes on the surface. Nutraceutical R&D never got the same investment, so an important question has rarely been asked: what happens to skin when you act on its internal biology?

The literature on oral actives for skin is large but fragmented. Thousands of studies show improvement in individual skin aging markers. What’s missing is the synthesis: a map of the full network of skin aging, and a protocol built against it that accounts for how its actives interact, aimed at rejuvenating skin.

That synthesis is why Epillon exists. Our research program is building the map for how skin longevity works, offering a new layer of skin care that works beneath the surface.

In vitro program
Multiple in-vitro panels in human dermal fibroblasts. Results: Dec 2026
Human clinical trials
Multiple, dermatologist-supervised RCTs, 2027-2029.
Dr. François-Xavier PellayChief Scientific Officer

We're building the map on skin longevity

To develop a truly comprehensive, evidence-based solution for skin rejuvenation, we spent years mapping how aging science and skin biology intersect: ten factors of skin aging across three domains, and how each one feeds the others. It's the framework our research is built on, and the one every Formula 01 active is chosen against.

Senescent Cells & SASP

Under enough stress, cells stop dividing but refuse to die, sometimes called “zombie cells.” They linger and secrete a steady stream of inflammatory signals and tissue-degrading enzymes, known as the SASP. That secretion is the damage: it inflames nearby tissue, dissolves the matrix, and nudges healthy neighbors toward the same fate.

Molecular Stress

Skin aging begins with assault. Intrinsic time and extrinsic exposure (UV, pollution, diet, lifestyle) generate a cluster of damaging signals: oxidation, glycation, inflammation, and the secretions of senescent cells. They amplify one another and drive the damage inward, into the cells themselves, where the cellular failures they trigger will, in turn, loop back and create more damage drivers.

FAQ

Got questions? We’ve got expert-backed answers to help you navigate every step of your journey.

Formula 01 is formulated from published mechanistic research on each active. There is no finished-product human data yet. A mechanistic in vitro program is running now at an independent contract research laboratory, and multiple dermatologist-supervised randomized controlled trials follow, based on the outcome of the in vitro results. We will publish results, including negative findings, and send them to partner practices first.

Formula 01 works with skin's own rebuilding cycle. The surface renews in about four weeks. Collagen and elastin turn over across months. We suggest patients evaluate at three months and plan for six.

Formula 01 is designed to sit alongside topical regimens, energy-based devices, injectables, and resurfacing. Ingestible and topical act on different layers. Full contraindication and interaction guidance, including pregnancy, anticoagulant therapy, and photosensitizing agents, is documented in the clinical white paper.

No. Collagen supplements deliver one substrate. Aged skin is not short of raw material, it is short of the cellular machinery to build with. Formula 01 acts across the damage drivers, cellular function, and matrix rebuilding, while adding bioactive collagen peptides that act as a signal, and the requisite cofactors and building blocks to rebuild it. 

Yes. Founding partners receive personal allocation ahead of launch. We would like you to have your own experience of it.

Your practice gets initial in-clinic inventory, an in-clinic welcome kit and a co-branded  webpage for patients to sign up for refills. We handle all recurring fulfillment, shipping, customer service, and reorders on our end, making this as operationally light as possible.